Press release
Malaria Vaccine Market Booms with New WHO Approvals in 2025 | Major Companies are GlaxoSmithKline Biologicals (GSK), the Swiss Serum Institute, WRAIR, Sanaria.
Global Malaria Vaccines market is expected to grow at a CAGR Of 31.85% during the forecast period 2024-2031.The Malaria Vaccines Market takes center stage in DataM Intelligence's latest comprehensive research, where industry experts deliver cutting-edge analysis powered by robust data analytics and strategic market intelligence. This groundbreaking study dives deep into the competitive ecosystem, spotlighting market leaders and their innovative approaches to product development, competitive pricing models, financial performance, and expansion strategies. The research unveils critical market forces, competitive positioning, and breakthrough trends that will define the industry's trajectory in the coming years, providing stakeholders with actionable intelligence to navigate this rapidly evolving marketplace.
Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access):- https://datamintelligence.com/download-sample/malaria-vaccines-market?rk
The malaria vaccines market comprises all research, development, manufacturing, distribution, and adoption of vaccines targeting Plasmodium parasites, primarily falciparum. It includes both first-generation vaccines like RTS,S/AS01 (Mosquirix) and promising second-generation candidates such as R21/Matrix-M, plus emerging technologies (e.g., whole-sporozoite, mRNA-based) under clinical development .
Key Trends
Next‐generation & combination vaccines
Focus is shifting toward multi-stage and combination vaccines that target both early and blood stages of the parasite's lifecycle.
Nanotechnology & mRNA platforms
Advanced platforms, including nanoparticles and mRNA-based vaccines, are being explored to improve immune response and durability.
Supplier diversification & local production
Efforts are ongoing to build manufacturing capacity in malaria-endemic regions and reduce dependence on single-source suppliers.
Public-private collaboration & AI integration
Strategic partnerships between governments, NGOs, and pharmaceutical firms are accelerating R&D, with AI increasingly used for target discovery.
Malaria Vaccines Market: Industry Giants and Emerging Leaders:
GlaxoSmithKline Biologicals (GSK), the Swiss Serum Institute, WRAIR, Sanaria, BioNTech, Nobelpharma, CellFree Sciences, Sumaya Biotech, VLP Therapeutics LLC, Bharat Biotech, Serum Institute of India, Novavax, Kenya medical research institute.
Malaria Vaccines Industry News:
RTS,S vaccine manufacturers plan to reduce costs to under $5 per dose by 2028, enhancing accessibility.
The R21/Matrix-M vaccine received WHO prequalification and has begun rollout in several African nations.
Serum Institute aims to manufacture up to 200 million doses annually, supporting global supply.
New vaccine candidates using whole-parasite and mRNA technologies are in early-stage trials, showing promising results.
Research Methodology
Our comprehensive research approach leverages a dual-methodology framework that seamlessly integrates qualitative insights with quantitative data analysis to deliver robust market intelligence. The process begins with extensive secondary research, where we meticulously collect information from authoritative industry publications, proprietary databases, and verified market sources. This foundation is strengthened through targeted primary research initiatives, including strategic surveys and in-depth interviews with industry veterans, market experts, and key stakeholders.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/malaria-vaccines-market
Segment Covered in the Malaria Vaccines Market:
By Type of Infectious Agents: Plasmodium Falciparum, Species of Anopheles, P. vivax, P. malaria, Others.
By Type of Vaccines: Erythrocytic, Pre erythrocytic, Multi antigen, Others.
By End User: Hospitals, Speciality Clinics, Retail Pharmacy, Others.
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Top-down and bottom-up approach for regional analysis
Regional Analysis for Malaria Vaccines Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Frequently asked questions:
➠ What is the global sales value, production value, consumption value, import and export of Malaria Vaccines market?
➠ Who are the global key manufacturers of the Malaria Vaccines Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?
➠ What are the Malaria Vaccines market opportunities and threats faced by the vendors in the global Malaria Vaccines Industry?
➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➠ What focused approach and constraints are holding the Malaria Vaccines market?
➠ What are the different sales, marketing, and distribution channels in the global industry?
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Looking For Detailed Full Report? Get it here: https://datamintelligence.com/buy-now-page?report=malaria-vaccines-market
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Malaria Vaccine Market Booms with New WHO Approvals in 2025 | Major Companies are GlaxoSmithKline Biologicals (GSK), the Swiss Serum Institute, WRAIR, Sanaria. here
News-ID: 4082699 • Views: …
More Releases from DataM Intelligence 4market Research LLP

Breast Cancer Drugs Market Overview: Trends, Innovations, and Future Outlook | M …
The Global Breast Cancer Drugs Market reached USD 28.7 billion in 2022 and is projected to witness lucrative growth by reaching USD 57.1 billion by 2031. The Global Breast Cancer Drugs Market is expected to exhibit a CAGR of 9.2% during the forecast period 2024-2031.
The Breast Cancer Drugs Market takes center stage in DataM Intelligence's latest comprehensive research, where industry experts deliver cutting-edge analysis powered by robust data analytics and…

Next-Gen Hair Loss Medications Powered by Biotechnology and Stem Cell Regenerati …
Global Hair Loss Medication Market is expected to grow at a CAGR of 5.62% during the forecast period (2024-2031)
The Hair Loss Medication Market takes center stage in DataM Intelligence's latest comprehensive research, where industry experts deliver cutting-edge analysis powered by robust data analytics and strategic market intelligence. This groundbreaking study dives deep into the competitive ecosystem, spotlighting market leaders and their innovative approaches to product development, competitive…

Industrial Grade Oxalic Acid Market | Future Outlook, Trends, and Expansion Insi …
Global Oxalic Acid Market reached US$ 1.5 billion in 2022 and is expected to reach US$ 2.0 billion by 2031, growing with a CAGR of 4.3% during the forecast period 2024-2031.
The Oxalic Acid Market takes center stage in DataM Intelligence's latest comprehensive research, where industry experts deliver cutting-edge analysis powered by robust data analytics and strategic market intelligence. This groundbreaking study dives deep into the competitive ecosystem, spotlighting market leaders…

Warm Water Aquaculture Feed Market: Rising Demand from Tilapia and Shrimp Farmin …
The Global Warm Water Aquaculture Feed Market reached US$ 4.41 billion in 2022 and is expected to reach US$ 5.96 billion by 2031, growing with a CAGR of 3.85% during the forecast period 2024-2031.
The Warm Water Aquaculture Feed Market takes center stage in DataM Intelligence's latest comprehensive research, where industry experts deliver cutting-edge analysis powered by robust data analytics and strategic market intelligence. This groundbreaking study dives deep into the…
More Releases for Vaccine
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%.
An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the…